A clinical trial to evaluate the combination of BGB-11417 and BRUKINSA in patients with mantle cell lymphoma (MCL) and Waldenström's macroglobulinemia (WM)
Latest Information Update: 18 May 2021
At a glance
- Drugs Sonrotoclax (Primary) ; Zanubrutinib (Primary)
- Indications Mantle-cell lymphoma; Waldenstrom's macroglobulinaemia
- Focus Therapeutic Use
- 18 May 2021 New trial record